You have 9 free searches left this month | for more free features.

City

Knoxville (3)

Saint Paul (3)

Miami (2)

Edegem (1)

Kiel (1)

Condition

Multiple Sclerosis (2)

Hepatic Function Abnormal (1)

Renal Impairment (1)

Overall Status

Completed (4)

Sign in for free

Phase

phase 1 (4)

Sponsor

Sanofi (4)

Collaborator

Intervention

tolebrutinib (4)

gemfibrozil (1)

placebo (1)

rifampicin (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

tolebrutinib

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Renal Impairment Trial in Germany, United States (tolebrutinib)

Completed

Renal Impairment

tolebrutinib

Miami, Florida
+3 more

Jan 24, 2023

Hepatic Function Abnormal Trial in Belgium, United States (tolebrutinib)

Completed

Hepatic Function Abnormal

tolebrutinib

Miami, Florida
+3 more

Nov 7, 2022

Multiple Sclerosis Trial in Saint Paul (Tolebrutinib, gemfibrozil, rifampicin)

Completed

Multiple Sclerosis

Tolebrutinib
+2 more

Saint Paul, Minnesota

Prism Research-Site Number:8400001

Sep 26, 2023

Multiple Sclerosis Trial in Knoxville (Tolebrutinib, Placebo)

Completed

Multiple Sclerosis

Tolebrutinib
Placebo

Knoxville, Tennessee

New Orleans Clinical Research Site Number : 8400001

Oct 24, 2023